A Medtech Exec, Pharma Exec and Venture Capitalist Walk Onto a Stage and Talk Digital Health

Posted by Pete Masloski on January 10, 2019

Vijesh Unnikrishnan co-wrote this article with Pete Masloski

It’s not often that you get medtech, pharma and venture capital executives to sit on the same panel and participate with enthusiasm and excitement—unless the topic is digital health, where the cross-pollination of ideas and solutions across industry players is becoming more of a norm than an exception. At ZS’s recent Digital and Connected Health Summit, we were fortunate to host a panel of experts who engaged us in a lively discussion: Andy Atwell, executive director of new business development at Omron; Pankaj Dubey, senior director, U.S. commercial, at Abbvie; Divya Varshney, digital health lead at Baxter; and Megan Zweig, director of research at Rock Health. The panelists shared their excitement and optimism, and some examples of how they see life sciences


>
Read More

Why Devices Don’t—and Shouldn’t—Require the Same Clinical Evidence as Drugs

Posted by Roz Lawson on January 19, 2016

Many of my colleagues in Europe work in pharmaceuticals and want to know why medical devices typically don’t have an approval process based on randomised clinical trials. Medical devices shouldn’t require the same clinical evidence as drugs for both clinical and commercial reasonsand, in fact, they can’t.


>
Read More